InsiderDB
Sign inStart free trial

Danaher (DHR)

Healthcare · Medical - Diagnostics & Research

26 members of Congress have disclosed 75 trades in Danaher (DHR) since 2014: 29 buys and 46 sales. The most recent was disclosed on Nov 5, 2026. 4 trades were made by members of a committee that oversees Danaher's industry.

Trades disclosed
75
Members trading
26
Buys / sells
29 / 46
Reported value
$523K–$2.1M

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow DHR

What else is happening at DHR

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. DHRCompany announcement·SEC EDGAR

    DHR: Financial results

    Filed 8-K for an event or period dated 2026-10-21. Financial results.

    Public: Oct 20, 2026, 5:43 PM EDTEvent / period: Oct 21, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. DHRFinancial report·SEC EDGAR

    DHR: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-25. Read the company report for its disclosures.

    Public: Oct 20, 2026, 5:40 PM EDTEvent / period: Sep 25, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. DHRLobbying report·Lobbying disclosures

    DHR: third_quarter 2026 lobbying report

    Issues related to biotechnology, cell and gene therapy General issues related to tariffs

    Public: Oct 20, 2026, 3:43 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  4. DHRLobbying report·Lobbying disclosures

    DHR: third_quarter 2026 lobbying report

    Issues Related to biotech and bio manufacturing.

    Public: Oct 20, 2026, 1:18 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  5. DHRLobbying report·Lobbying disclosures

    DHR: third_quarter 2026 lobbying report

    Issues related to a manufacturing rebate program for domestic production of life sciences products.

    Public: Oct 20, 2026, 11:14 AM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

Committee overlaps

Trades by members of a committee that oversees Danaher's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded DHR

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.